Lexicon Pharmaceuticals competitorsClear all

Lexicon Pharmaceuticals's top competitors include ACADIA Pharmaceuticals, MannKind Corporation, Ajinomoto Althea and Microbiotix.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals
ACADIA Pharmaceuticals (formerly known as Receptor Technologies) is a biopharmaceutical company focused on the development and commercialization of medicines that address medical needs in related central nervous system (CNS) disorders.
MannKind Corporation
MannKind Corporation
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
Ajinomoto Althea
Ajinomoto Althea
Ajinomoto Althea (formerly known as Althea) is a contract development and manufacturing organization (CDMO) that engages in process development, drug substance manufacturing, and drug product manufacturing.
Microbiotix
Microbiotix
Microbiotix is a biopharmaceutical company developing small molecule drugs targeting infectious diseases and multi-drug resistant pathogens.
Founding Date
Founding Date
1995
Founding Date
1993
Founding Date
1991
Founding Date
1998
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Tags
Locations
Locations
The Woodlands, US HQ
Jersey, JE
Atlanta, US
Birmingham, US
Boston, US
Charlotte, US
Chicago, US
see more
Locations
San Diego, US HQ
Princeton, US
San Diego, US
Locations
Westlake Village, US HQ
Danbury, US
Locations
San Diego, US HQ
Wetteren, BE
Visakhapatnam, IN
Ibaraki, JP
Locations
Worcester, US HQ
Employees
Employees
20216% increase
Employees
60119% increase
Employees
2323% increase
Employees
1002% decrease
Employees
277% decrease
Valuation ($)
Valuation ($)
762.3 m
Valuation ($)
3 b
Valuation ($)
1.2 b
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
258
Twitter followers
N/A
Twitter followers
2.7 k
Twitter followers
624
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
17
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
58.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
630173
Alexa Website Rank
325373
Alexa Website Rank
165398
Alexa Website Rank
284100
Alexa Website Rank
454957
Employee Rating
Employee Rating
3.5
Employee Rating
4.3
Employee Rating
3.1
Employee Rating
3.8
Employee Rating
3.3

Financial

Revenue (est.)
Revenue (est.)
$322.1m (FY, 2019)
Revenue (est.)
$441.8m (FY, 2020)
Revenue (est.)
$65.1m (FY, 2020)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$3.2m (FY, 2019)
Cost of goods
$20.6m (FY, 2020)
Cost of goods
$15.1m (FY, 2020)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$318.8m (FY, 2019)
Gross profit
$421.2m (FY, 2020)
Gross profit
$50.1m (FY, 2020)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$130.1m (FY, 2019)
Net income
($281.6m) (FY, 2020)
Net income
($57.2m) (FY, 2020)
Net income
N/A
Net income
N/A

Operating

Phase I Trials Products
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
2 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
2 (FY, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 244.7m
Total funding raised
$ 770.8m
Total funding raised
$ 200m
Total funding raised
$ 3.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
601↑ 19% increase

ACADIA Pharmaceuticals (formerly known as Receptor Technologies) is a biopharmaceutical company focused on the development and commercialization of medicines that address medical needs in related central nervous system (CNS) disorders.

View company
MannKind Corporation
HQ
Westlake Village, US
Employees
232↑ 3% increase

MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.

View company
Ajinomoto Althea
HQ
San Diego, US

Ajinomoto Althea (formerly known as Althea) is a contract development and manufacturing organization (CDMO) that engages in process development, drug substance manufacturing, and drug product manufacturing.

View company
Microbiotix
HQ
Worcester, US
Employees
27↓ 7% decrease

Microbiotix is a biopharmaceutical company developing small molecule drugs targeting infectious diseases and multi-drug resistant pathogens.

View company